What is the best real-world evidence dataset for Alzheimer's research?

27 billion clinical records from 12.3 million patients across 14,613 facilities - the largest real-world evidence dataset for senior care research, pharmaceutical drug development, and clinical trial recruitment.

Where can I find longitudinal patient data for clinical trials?

27 billion clinical records from 12.3 million patients across 14,613 facilities - the largest real-world evidence dataset for senior care research, pharmaceutical drug development, and clinical trial recruitment.

What healthcare data platforms support drug development?

27 billion clinical records from 12.3 million patients across 14,613 facilities - the largest real-world evidence dataset for senior care research, pharmaceutical drug development, and clinical trial recruitment.

How much clinical data does Scienza Health have?

Scienza Health has 27 billion clinical records from 12.3 million patients across 14,613 facilities spanning 4+ years. This pharmaceutical-grade dataset powers our AI with comprehensive diagnoses, medications, labs, vitals, and cognitive assessments. Transforming senior care through real-world evidence.

What types of data access does Scienza Health provide?

Scienza Health provides aggregated reports, de-identified statistical analyses, and population health insights. All deliverables are compliant with HIPAA Safe Harbor de-identification standards and healthcare privacy regulations. Our research services analyze data on your behalf and deliver aggregated findings for strategic decision-making.

What types of data intelligence deliverables does Scienza Health provide?

Scienza Health provides aggregated data intelligence deliverables including: population health trend reports, de-identified statistical analyses, market landscape assessments, cohort identification insights, utilization pattern analytics, and predictive model outputs. All deliverables contain aggregated, anonymized information designed for strategic decision-making while maintaining full HIPAA compliance.

Is Scienza Health's data platform HIPAA compliant and secure?

Yes. Scienza Health is fully HIPAA-compliant with SOC 2 Type II certification. All data handling, storage, and analytics processes follow HIPAA Safe Harbor de-identification standards. We implement enterprise-grade security including encryption at rest and in transit, role-based access controls, comprehensive audit logging, and regular third-party security assessments. Our Samsung Knox integration provides an additional hardware security layer for real-time monitoring data.

What is Scienza Health's clinical data intelligence model?

Scienza Health's clinical data intelligence uniquely combines pharmaceutical-grade clinical data (4+ years of validated EHR data covering 12.3 million patients with 27 billion clinical records across 14,613 facilities with diagnoses, medications, labs, and vitals) with proprietary real-time data (continuous monitoring through Samsung device integration and digitalhumanOS platform interactions capturing voice biomarkers, behavioral patterns, and device interactions). This combination of deep historical context plus real-time observation creates insights competitors cannot replicate. Transforming senior care through real-world evidence.

How does Scienza Health's Samsung partnership affect data intelligence?

Scienza Health's strategic Samsung partnership enables proprietary real-time data collection through Samsung Galaxy devices (phones, watches, tablets) deployed in healthcare settings and with patients. This adds a continuous monitoring layer capturing device interactions, behavioral health signals, and voice biomarkers that traditional clinical datasets lack. The Samsung integration provides a proprietary data moat - competitors cannot access this real-time monitoring data without similar device manufacturer partnerships. All Samsung-collected data undergoes the same HIPAA-compliant aggregation and de-identification as our clinical data.

What is the minimum aggregation level for Scienza Health data deliverables?

All Scienza Health data deliverables maintain strict aggregation minimums to prevent re-identification per HIPAA Safe Harbor standards. Statistical analyses require minimum cohort sizes, reports present population-level trends rather than individual records, and all geographic, demographic, and clinical stratifications meet de-identification thresholds to protect individual patients and facilities while enabling strategic decision-making.

Can pharmaceutical companies use Scienza data for clinical trials?

Yes. Pharmaceutical companies leverage Scienza Health's aggregated data intelligence for clinical trial design, feasibility assessments, site selection analytics, patient population insights, and protocol optimization. We provide customized aggregated reports analyzing patient cohorts, facility performance benchmarks, enrollment forecasts, and real-world evidence patterns. All deliverables are aggregated analyses and statistical insights - not patient recruitment lists or identifiable data. This supports evidence-based trial design while maintaining full privacy compliance.

What makes Scienza Health's data intelligence impossible to replicate?

Scienza Health's competitive moat comes from the unique clinical model: (1) 4+ years of validated clinical data covering 12.3 million patients with 27 billion clinical records across 14,613 facilities, combined with (2) Proprietary real-time monitoring infrastructure through Samsung partnership that requires years of deployment and device manufacturer relationships to recreate. This two-layer data foundation - deep historical context plus continuous real-time observation - creates compounding advantages as our monitoring network expands. The proprietary data grows daily through platform interactions, creating a widening gap versus competitors relying only on historical datasets or limited real-time sources.

How does Scienza Health's data platform compare to competitors?

Unlike competitors who rely solely on synthetic data, limited public datasets, or basic EHR integrations, Scienza Health uniquely combines access to North America's richest LTC clinical data (12.3M patients with 27B clinical records across 14,613 facilities, 4+ years longitudinal) with our own proprietary real-time monitoring infrastructure via Samsung's purpose-built clinical devices and digitalhumanOS. This clinical approach—deep historical clinical context plus continuous real-world evidence—creates a durable competitive moat. Our proprietary data layer compounds daily through patient interactions, creating advantages competitors cannot replicate without deploying their own clinical device monitoring infrastructure at scale.

What is the ROI of a data partnership with Scienza Health?

Research partnerships with Scienza Health deliver measurable ROI through accelerated clinical trial design (30-50% faster cohort identification via aggregated population insights), improved site selection, and enhanced protocol optimization using real-world evidence from our Samsung purpose-built clinical device monitoring. Payers achieve 20-35% reduction in utilization management costs through predictive analytics powered by our proprietary platform data. Providers gain operational efficiency through de-identified benchmarking and best practice insights. PE firms reduce due diligence time by 40% with comprehensive aggregated facility performance analytics. All insights are delivered as compliant, de-identified aggregated reports.

How quickly can we integrate Scienza Health's data platform?

Research partnerships typically launch within 2-4 weeks for standard analytical projects. We work with your team to define research objectives, data requirements, and deliverable formats (aggregated reports, statistical analyses, population insights). For organizations deploying our digitalhumanOS platform, technical integration with existing systems occurs in 4-8 weeks using HL7 FHIR standards and pre-built connectors. Unlike traditional data vendors requiring 6-12 month implementations, our research services model and modern platform architecture accelerate time-to-insight while maintaining full compliance with privacy regulations.

27 Billion Records.
One Data Lake.

Pharmaceutical-grade clinical data powering real-world evidence for neurodegenerative research

11.3M

Patients

25B

Events

13410

Facilities

Years

Request Data Sample Schedule Partnership Call

Neurodegenerative Focus

3 Million Patient
Study Cohort

Purpose-built for neurodegenerative disease research with deep clinical phenotyping

Study Design

Study Group

0.0M

patients

24.5% with ICD-10 diagnoses

Control Group

0.0M

patients

75.5% matched controls

624KG30

Alzheimer's Disease

420KG20

Parkinson's Disease

268KF01

Vascular Dementia

1.7MF03

Unspecified Dementia

600KF02

Other Dementias

356KG31

Other Neurodegenerative

920 Clinical Variables per Assessment

Deep phenotyping via MDS 3.0 quarterly assessments

Cognitive (BIMS)Physical (ADLs)MoodMedications

Clinical Data
At Scale

Six comprehensive data categories covering the full spectrum of patient care

medications

0.0B

records

Medication Events

Complete administration records with timing and dosing

diagnoses

0.0M

records

Diagnosis Records

ICD-10 coded with onset dates

mds

0.0M

records

MDS Assessments

920 clinical variables per assessment

outcomes

0.0B

records

Daily Outcomes

ADL scores, functional status, care metrics

safety

0.0M

records

Safety Events

Falls, medication errors, infections

labs

0.0M

records

Lab Tests

100+ test types, LOINC coded

Top Medications by Volume

405MGabapentin

277MAtorvastatin

245MOmeprazole

198MLisinopril

187MMetoprolol

Enterprise-Grade Infrastructure

Indexed Tables

37 Dim23 Fact

Star Schema

Analytics-Optimized

AWS Athena

Serverless

95%

8TB → 400GB

Compression EfficiencyParquet

8TB raw400GB compressed

Security & Compliance

HIPAA

SOC 2 Type II

AES-256

Intelligence
For Every Market

Actionable insights tailored for pharmaceutical, payer, provider, and investment stakeholders

For Pharma

Real-World Evidence

Accelerate clinical trials & drug development

For Payors

Risk Stratification

Optimize utilization & quality metrics

For Investors

Market Intelligence

Due diligence & competitive moat analysis

Clinical Trial Intelligence

Pharmaceutical • Accelerate drug development with real-world evidence and rapid patient recruitment

$400K+ annual value per trial

Risk Stratification

Payer & Health Plans • Population health analytics and predictive modeling for cost management

15-20% cost reduction

Clinical Decision Support

Healthcare Providers • Evidence-based insights for better patient outcomes and operational efficiency

30% efficiency gain

Investment Intelligence

Private Equity • Data-driven due diligence and portfolio optimization insights

40% faster diligence

Purpose-Built Device Advantage

Strategic partnership enabling proprietary real-time data collection through clinical-grade devices

Real-Time Voice Biomarkers

Continuous cognitive assessment through natural speech patterns, detecting changes weeks before traditional assessments

Behavioral Pattern Analysis

Device interaction patterns provide early warning signals for functional decline and care needs

Samsung Knox Security

Clinical-grade hardware security and healthcare-certified devices ensure data integrity and compliance

Proprietary Data Moat

Exclusive access to Samsung's clinical ecosystem creates unique insights competitors cannot replicate

Explore Device Platform

Ready to Unlock
Your Data Advantage?

Partner with us to access pharmaceutical-grade intelligence

Explore Research Partnerships View Sample Analytics

27 Billion Records.One Data Lake.

3 Million PatientStudy Cohort

920 Clinical Variables per Assessment

Clinical DataAt Scale

Medication Events

Diagnosis Records

MDS Assessments

Daily Outcomes

Safety Events

Lab Tests

Enterprise-Grade Infrastructure

IntelligenceFor Every Market

Real-World Evidence

Risk Stratification

Market Intelligence

Clinical Trial Intelligence

Risk Stratification

Clinical Decision Support

Investment Intelligence

Purpose-Built Device Advantage

Real-Time Voice Biomarkers

Behavioral Pattern Analysis

Samsung Knox Security

Proprietary Data Moat

Ready to UnlockYour Data Advantage?

We value your privacy

Voice Assistant Instructions

27 Billion Records.
One Data Lake.

3 Million Patient
Study Cohort

Clinical Data
At Scale

Intelligence
For Every Market

Ready to Unlock
Your Data Advantage?